{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-039399","form_type":"8-K","ticker":"IBRX","cik":"0001326110","company_name":"ImmunityBio, Inc.","filed_at":"2023-02-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.417331+00:00","generated_at":"2026-06-19T13:21:40.240064+00:00","sec_items":["2.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"ImmunityBio reports estimated cash and securities of $108M as of Dec 31, 2022","bullets":["Preliminary estimate of cash, cash equivalents and marketable securities as of Dec 31, 2022: approximately $108.0M.","Includes $104.6M cash & equivalents and $3.4M marketable securities.","These are preliminary estimates; final results may differ and will be in Form 10-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-039399","json":"https://secwatch.observer/filing/0001193125-23-039399.json","markdown":"https://secwatch.observer/filing/0001193125-23-039399.md","text":"https://secwatch.observer/filing/0001193125-23-039399.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326110/000119312523039399/0001193125-23-039399-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326110/000119312523039399/d403722d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T13:21:40.240064+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}